tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
CCCC is currently covered by 3 analysts with an average price target of $7. This is a potential upside of $4.01 (134.11%) from yesterday's end of day stock price of $2.99.
C4 Therapeutics's activity chart (see below) currently has 72 price targets and 77 ratings on display. The stock rating distribution of CCCC is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 40.82% with an average time for these price targets to be met of 69.05 days.
Highest price target for CCCC is $7, Lowest price target is $7, average price target is $7.
Most recent stock forecast was given by BRADLEY CANINO from STIFEL on 23-Mar-2026. First documented stock forecast 27-Oct-2020.
Currently out of the existing stock ratings of CCCC, 4 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
$7
$4.05 (137.29%)
6 months 13 days ago
(23-Mar-2026)
3/11 (27.27%)
$4.44 (173.44%)
122
Buy Since 11-Apr-2022
$7
$2.74 (64.32%)
$20
7 months 9 days ago
(27-Feb-2026)
0/6 (0%)
$4.3 (159.26%)
Buy Since 24-Jun-2021
7 months 13 days ago
(23-Feb-2026)
0/4 (0%)
$50.77 (152.78%)
Buy Since 23-Sep-2025
$10
$5.74 (134.74%)
$12
1 years 13 days ago
(23-Sep-2025)
5/8 (62.5%)
$7.41 (286.10%)
129
Buy Since 22-Sep-2025
$6
$1.74 (40.85%)
$6
1 years 14 days ago
(22-Sep-2025)
1/3 (33.33%)
$3.39 (129.89%)
16
What is CCCC (C4 Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on CCCC (C4 Therapeutics)?
Which analyst has the most public recommendations on CCCC (C4 Therapeutics)?
Which analyst is the currently most bullish on CCCC (C4 Therapeutics)?
Which analyst is the currently most reserved on CCCC (C4 Therapeutics)?
